User menu

Improvement in das28 response through 1-yr of golimumab treatment in pts with active RA despite treatment with MTX: A randomized, double blind, placebo-controlled, dose-ranging trial

Bibliographic reference Dasgupta, B. ; Durez, Patrick ; Kay, J. ; Matteson, E. L. ; Nash, P. ; et. al. Improvement in das28 response through 1-yr of golimumab treatment in pts with active RA despite treatment with MTX: A randomized, double blind, placebo-controlled, dose-ranging trial.Annual Meeting of the British-Society-Rheumatology/Spring Meeting of British Health Professional in Rheumatology (Liverpool (England), Apr 22-25, 2007). In: Rheumatology, Vol. 47, p. II50-II51 (2008)
Permanent URL http://hdl.handle.net/2078.1/59285